We are honored to announce that Prof. Dr. A. Douglas Kinghorn will serve as the Chair of the 2024 Tu Youyou Award Committee.

Name: Prof. Dr. A. Douglas Kinghorn
Affiliation: College of Pharmacy, The Ohio State University, USA

Prof. Dr. Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and edited or co-edited 40 scientific volumes.

The 2024 Tu Youyou Award Committee, under Prof. Dr. Kinghorn's guidance, will focus on identifying innovative research in the fields of natural products chemistry and medicinal chemistry. The committee will aim to identify groundbreaking work with the potential to lead to significant advancements in these areas.

We are confident that, with Prof. Dr. Kinghorn at the helm, the 2024 Tu Youyou Award will continue to inspire excellence and innovation in the related fields.

About the Tu Youyou Award
Established in 2016, the Tu Youyou Award seeks to honor those who excel in the fields of natural products chemistry and medicinal chemistry. This award offers a total prize of CHF 100,000, which will be equally divided among the winners if there is more than one, with each recipient receiving an award medal.

The 2024 Tu Youyou Award remains open for nominations until 31 December 2024. We encourage all eligible candidates to participate in this prestigious recognition, as this award not only honors individual achievement but also encourages further scientific exchange, exploration and discovery in critical areas of medicine.

If you are interested in participating, please visit the Tu Youyou Award website for more information on the nomination requirements.

Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.

We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.

We invite you to explore and learn more about these new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue	biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article
	Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue	surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article
	Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue	ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article
	Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue	hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article
	Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue	lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee ([email protected]) if you would like to create more new journals.

The third ASBMB-BSC Symposium on the Interplay between Epigenetic Regulation and Genome Integrity will be held from 21 to 25 October 2024, in Wuhan, China. The conference is co-organized by the Biophysics Society of China (BSC) and the American Society for Biochemistry and Molecular Biology (ASBMB).

Topics include the following:

• Epigenetic regulation of genome replication;
• Dynamic epigenetic alterations maintaining genome stability;
• Chromatin-based epigenetic inheritance;
• The role of epigenetic alterations in cancer and aging.

The following MDPI journals will be represented at the conference:

• CIMB;
• Genes;
• IJMS;
• Biomedicines;
• Epigenomes;
• JDB.

If you are planning to attend this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at our booth #9 and answering any questions that you may have. For more information about the conference, please click the following link: https://www.bsc.org.cn/bsc-asbmb-epigenetics/.

As a leader in open access publishing, MDPI is eager to explore new collaboration opportunities, including the launch of new journals and the transfer of existing ones. At present, MDPI publishes over 400 journals, more than 160 of which have established partnerships with academic organizations. Additionally, we publish 19 association journals.

In order to enhance exchange and cooperation with scientific researchers and share the results of open science, MDPI invites experts and scholars from various fields to submit proposals for new journal collaboration opportunities. If your proposal is approved, you could take on the role of Editor-in-Chief, Deputy Editor-in-Chief, or Editorial Board Member of the journal. This position allows you to manage the manuscript review process alongside our editorial department, participate in calls for papers, strengthen your network with scholars in the field, expand scientific research cooperation, enhance your personal and academic influence internationally, and play a leading role in academia.

Once the new journal is online, MDPI will provide a variety of promotional channels to market the journal internationally.

MDPI will offer various promotional channels to enhance its visibility and promote it internationally.

How can you determine the theme of a new journal?

• Assess research hotspots/academic frontiers;
• Assess pioneers in the field/key research directions of universities;
• Determine whether MDPI has already established a journal in the field.

You can browse MDPI’s existing journals at the following link: https://www.mdpi.com/about/journals.

Advantages of collaborating with MDPI:

• MDPI is a global leader in open-access publishing with extensive academic resources.
• MDPI offers a professional publishing team that provides comprehensive support throughout the publishing process.
• MDPI’s diverse promotional platforms and channels help journals quickly increase their international visibility and influence.

We invite you to submit new journal proposal here, and contribute to academic development! In addition, if your institution (university, institute, college, national key laboratory, society, etc.) intends to establish a journal, you can also submit a draft to MDPI on its behalf.

MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.

We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:

• Biology and Life Sciences;
• Chemistry and Materials Sciences;
• Engineering;
• Environmental and Earth Sciences;
• Medicine and Pharmacology;
• Public Health and Healthcare;
• Others.

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

In order to further enhance the international influence of the journal Biomedicines (ISSN: 2227-9059), promote the academic exchange of young scientists, and support the Editorial Board with additional expertise, Biomedicines is inviting interested and eligible early career researchers to apply for an Early Career Editorial Board (ECEB) membership.

Early Career Editorial Board (ECEB) members will hold the position for two years, with the possibility of renewal for a second term.

Application Eligibility:

• Completed their doctorate/Ph.D. degree within the past 10 years (we may consider granting exceptions for career interruptions, including medical and family leave, as well as relevant experience);
• Served as the first author on at least five peer-reviewed and published manuscripts (we may also consider three first-author original research papers if the articles have been cited);
• Having an impactful portfolio of publications in their field of research on human health and disease;
• Researchers that are currently (at the time of application) an assistant professor, research assistant professor, associate research scientist, post-doctoral fellow, or an equivalent early career position;
• Researchers that are active and engaged in their community (e.g., experienced at presenting at academic conferences or involved in professional organizations);
• ⁠Willingness to dedicate their time to assist in developing the journal with passion and enthusiasm.

Benefits of being an Early Career Editorial Board Member include the following:

• A certificate of appointment as an Early Career Editorial Board Member will be provided;
• The achievements of Early Career Editorial Board Members are publicized on the journal’s media platforms to improve academic visibility;
• There will be an opportunity to be promoted to an Editorial Board Member based on contributions;
• The journal will regularly acknowledge those who participate in the peer-review process on the journal’s website;
• There will be opportunities to participate in or host annual meetings and online seminars organized by the Editor-in-Chief and the Editorial Board Members.

Responsibilities of an Early Career Editorial Board Member include:

• Publicizing and promoting the journal at academic conferences and among peers;
• Selecting high-quality articles and preparing media content for promotion;
• Reviewing at least four manuscripts per year;
• Identifying potential reviewers for specific papers and assessing any potential ethical or policy-based questions that might arise due to the papers’ content;

• Supporting the development of the journal through various means, such as providing suggestions, promoting the journal via academic networks, academic conferences, and new media channels, etc.;
• Learning about the scholarly publishing landscape, including gaining an awareness of the manuscript review process, ethical considerations, and the strategies used by publishers.

Applications:
Please fill in the application form here.

Please send the application form and your academic résumé to [email protected] with the subject line “Early Career Editorial Board Application + Name + Institute + Research Expertise”.

Application deadline: 31 December 2024.

Selection Process and Announcement:
The selection process is as follows: initial screening of application materials → selection by Editor-in-Chief and Editorial Board Members → email notification → issuance of certificate of appointment.

Selection will be made within one month of the application deadline, and the results will be announced on the journal’s website.

MDPI will be attending the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ncRNA 2024) in Basel, Switzerland, which will take place from 7 to 9 October 2024. The conference will cover a broad range of topics, from basic biology to medical and technological applications. The sessions will take molecular biology through the topics of disease mechanisms, therapies, technologies, and bioinformatic approaches. Each session will be anchored by leading international speakers.

The following MDPI journals will be represented:

• Biology;
• Biomedicines;
• Biomolecules;
• Cells;
• Epigenomes;
• Genes;
• Life.

If you are attending the conference, please visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://sciforum.net/event/ncRNA2024.

MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.

We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

The 2024 International Conference of the Korean Society for Molecular and Cellular Biology will be held from 8 to 11 October 2024, in Jeju, Republic of Korea. The conference is organized by the Korean Society for Molecular and Cellular Biology, and promises a rich tapestry of scholarly exchange across various disciplines within biological and biomedical sciences.

The conference will feature four top keynote speakers in the field of life sciences, including two Nobel Prize winners, and scientists from more than thirty countries around the world participating in more than twenty scientific sessions on a variety of topics. The agenda includes symposiums showcasing pioneering research in life sciences, dedicated sessions for young academics, such as graduate students, postdoctoral researchers, and research professors, and a Bio Job Fair.

The following MDPI journals will be represented at the conference:

• International Journal of Molecular Sciences;
• Antioxidants;
• Biophysica;
• Current Issues in Molecular Biology;
• Kinases and Phosphatases;
• Metabolites;
• Microorganisms;
• Proteomes;
• Bioengineering;
• Biomedicines;
• BioMed;
• Biomolecules;
• Cancers;
• Genes;
• Journal of Molecular Pathology;
• Organoids;
• Plants;
• Non-Coding RNA;
• Sci;
• Journal of Fungi.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #99 and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.ksmcb.or.kr/icksmcb2024/main.html.

MDPI’s Young Investigator Awards recognize promising early career scientists, acknowledge their contributions, and foster collaboration within the scientific community. We are proud to announce the recipients for 2023, who were carefully selected by the journals’ esteemed Award Evaluation Committee.

We extend our heartfelt congratulations to the 79 winners of MDPI’s 2023 Young Investigator Awards for their excellent contributions in their research field. We look forward to seeing these rising stars continue to contribute to the advancement of science.

MDPI will continue to support and recognize the academic community. To explore details about the awardees by field, please visit the individual pages listed below:

Congratulations to all the winners for their exceptional contributions and dedication to advancing scientific research.

About MDPI Awards:
To support the academic community, particularly young researchers, and to enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help to elevate the profiles of talented individuals who have made outstanding achievements and are making significant contributions to advancements in their respective fields.

To find out more about MDPI awards, please click here.

Conference: The 11th Biennial Meeting of the Society for Free Radical Research-Asia and the Chinese National Conference of Redox Biology and Medicine 2024
Organizers: Society for Redox Biology and Medicine Branch of Biophysical Society of China;
The Material Biology and Intelligent Medicine Branch of Biophysical Society of China
Date: 21–23 October 2024
Place: Beijing, China

MDPI journals will be attending the 11th Biennial Meeting of the Society for Free Radical Research-Asia and the Chinese National Conference of Redox Biology and Medicine 2024 as exhibitors. This conference will be held in Beijing, China, from 21 to 23 October 2024.

After two decades of SFRR-Asia biennial meetings, we are marching into a new era regarding the exploration of redox biology and medicine at precision, mechanistic, and in vivo levels with innovative technology and the collaboration of multiple disciplines. The coming SFRR-Asia 2024, with the theme “The new era of precision redox biology and medicine: from basic research to the intervention of aging and diseases,” will provide an opportunity to embrace research progress in the field. This conference will address a range of topics, with a particular focus on three areas of research: basic research on redox biology and medicine, redox homeostasis in aging and diseases, and precision redox intervention and health management.

The following MDPI journals will be represented:

• Antioxidants;
• Biomedicines;
• Pharmaceuticals;
• Oxygen;
• International Journal of Molecular Sciences (IJMS);
• Current Issues in Molecular Biology (CIMB);
• Life;
• Obesities.

If you will be attending this conference, our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://sfrr-asia2024.tiemeeting.com.

Conference: 2024 BMES Annual Meeting
Date: 23–26 October 2024
Location: Baltimore, USA

MDPI will be attending the 2024 BMES Annual Meeting as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.

Established in 1968, the Biomedical Engineering Society (BMES) is a professional society for students, faculty, researchers, and industry professionals in the field of biomedical engineering. The conference aspect covers cancer treatment, heart disease, women’s health, global health disparities, and more. The meeting allows members to advocate for their innovative solutions, demonstrating their commitment to our society’s core value of health equity for all individuals. The Biomedical Engineering Society is governed by the BMES Board of Directors, and this board is elected from members of the society.

The following MDPI journals will be represented at the conference:

• Bioengineering;
• Sensors;
• Biomedicines;
• Biomechanics;
• Micromachines;
• Technologies;
• Applied Sciences;
• BioChem;
• BioTech;
• CIMB.

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us before visiting. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.bmes.org/bmes2024.

MDPI will attend the Biomolecular Horizons 2024 Congress, held from 22 to 26 September 2024 in Melbourne, Australia. This important forum will bring together three prestigious congresses, each with a strong history of attracting the bioscience and biotechnology communities to discuss and examine the latest developments and research:

• 26th Congress of the International Union of Biochemistry and Molecular Biology (IUBMB);
• 17th Congress of the Federation of Asian & Oceanian Biochemists & Molecular Biologists (FAOBMB);
• 22nd ComBio Conference (ComBio).

The overarching theme of the Biomolecular Horizons 2024 (BMH2024) Congress is “Discover, Create, Innovate”, which will be examined across the following key themes:

• Cell, Developmental and Stem Cell Biology;
• Biotechnology and Synthetic Biology;
• Microbial World;
• Cell Signalling and Metabolism;
• Genomics, Gene Regulation and Epigenetics;
• Bioinformatics, Computational Biology and Omics;
• Structural Biology and Biophysics;
• Molecular Basis of Disease;
• Molecular Physiology;
• Education.

The following MDPI journals will be represented:

• International Journal of Molecular Sciences;
• Biomolecules;
• Applied Biosciences;
• BioMedInformatics;
• Biomedicines;
• Cells;
• Applied Microbiology;
• BioTech;
• Biologics;
• Current Issues in Molecular Biology;
• Epigenomes;
• Genes;
• Journal of Developmental Biology;
• Journal of Molecular Pathology;
• Methods and Protocols;
• Muscles;
• Organoids;
• Signals;
• SynBio;
• Cardiogenetics.

If you are planning to attend the above conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions that you may have. For more information about the conference, please visit the following link: https://www.bmh2024.com/.

Conference: 36th European Congress of Pathology (ECP 2024)
Date: 7–11 September 2024
Location: Florence, Italy

The European Society of Pathology (ESP) and the Italian Society of Pathology invite you to the 36th European Congress of Pathology (ECP 2024). It will take place in the Congress Center, Fortezza da Basso, of the wonderful city of Florence from 7 to 11 September 2024. Over the last years, the ECP has become the worldwide leading congress in pathology, and the Florence congress will increase this legacy with top contributions in diagnostic training, research, and education. For these few days in September, pathologists, clinicians, molecular biologists, geneticists, bioinformaticians, IT experts, and our industry partners will gather for ECP 2024 and make Florence the capital of pathology. You can view the detailed conference topics at https://www.esp-congress.org/scientific-programme/topics.html.

MDPI will be attending the 36th European Congress of Pathology (ECP 2024), and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• Diagnostics;
• Biomedicines;
• Neurology International;
• Pathophysiology;
• Gastroenterology Insights;
• IJMS;
• Cancers;
• CIMB;
• Antibiotics;
• Zoonotic Diseases;
• BioMed;
• Dermatopathology;
• Tomography;
• Sclerosis.

If you plan to attend this conference, please contact us online. Our delegates look forward to meeting you in person at booth #L150 and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.esp-congress.org/.

In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.

The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.

On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.

MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.

MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.

In order to commemorate World Breastfeeding Week 2024, MDPI is launching a special webinar to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness on breastfeeding.

Breastfeeding plays a crucial role in the early development of infants, providing essential nutrients and antibodies that bolster the immune system and promote healthy growth. It fosters a strong bond between mother and child while reducing the risk of infections, allergies, and chronic conditions. Moreover, breastfeeding supports cognitive development and contributes to long-term health benefits, including lower risks of obesity and diabetes. For mothers, it aids post-partum recovery and reduces the risk of certain cancers. Promoting breastfeeding is vital for public health, ensuring the well-being of both infants and mothers and fostering a healthier future generation.

We are very much looking forward to seeing you at the MDPI World Breastfeeding Week Webinar 2024.

Date: 07 August 2024 at 03.00 p.m. CEST | 9:00 a.m. EDT | 9:00 p.m. CST Asia
Webinar ID: 839 4244 6710
Webinar Announcement: https://sciforum.net/event/MWBWW2

Register now for free!

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will inform you when the recording is available.

Keynote Speakers:

• Dr. Shela Hirani, University of Regina, Faculty of Nursing, Regina, Canada;
• Dr. Sylvia H. Ley, Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, U.S.A.;
• Dr. Natalie Shenker, Department of Surgery and Cancer, Imperial College London, London, England; Human Milk Foundation, Gossoms End Health Centre, Hertfordshire, England.

Relevant Special Issues:
“Health Promotion and Interventions for Marginalized Mothers and Children”
Guest Editor: Dr. Shela Hirani
Deadline for manuscript submissions: 30 June 2025

“Anxiety and Depressive Disorders among Pregnant and Breastfeeding Women”
Guest Editor: Dr. Georgios Eleftheriou
Deadline for manuscript submissions: 30 September 2024

“Association between Breast Milk Composition and Neonates Growth”
Guest Editor: Dr. Maria Elisabetta Baldassarre
Deadline for manuscript submissions: 15 December 2024

“Breastmilk for Healthy Development”
Guest Editors: Dr. Monika Zielińska-Pukos and Prof. Dr. Jadwiga Hamułka
Deadline for manuscript submissions: 25 October 2024

“What’s New in Breastfeeding?”
Guest Editor: Dr. Patricia Markham Risica
Deadline for manuscript submissions: 25 October 2024

“Breast Cancer: New Diagnostic and Therapeutic Approaches”
Guest Editors: Dr. Erika Bandini, Dr. Tania Rossi and Dr. Sara Bravaccini
Deadline for manuscript submissions: 31 January 2025

“Molecular and Pharmacological Basis of Breast Cancer Resistance to Therapies”
Guest Editors: Dr. Stefania Crucitta and Dr. Rossana Roncato
Deadline for manuscript submissions: 30 November 2024

“Women’s Special Issue Series: Biomedicines (2nd Edition)”
Guest Editors: Dr. Letizia Polito, Dr. Federica Falà and Dr. Riuko Ohashi
Deadline for manuscript submissions: 15 December 2024

“Impacts of Newborn Breast Milk Feeding”
Guest Editors: Dr. Ivan Hand and Dr. Lawrence M. Noble
Deadline for manuscript submissions: 10 January 2025

“Infant Feeding: Advances and Future Challenges: 2nd Edition”
Guest Editors: Dr. Evangelia Antoniou, Dr. Maria K. Tzitiridou-Chatzopoulou and Dr. Eirini Orovou
Deadline for manuscript submissions: 20 September 2024

“Promoting Breastfeeding and Human Milk in Infants”
Guest Editors: Dr. Pasqua Anna Quitadamo and Prof. Dr. Luigi Corvaglia
Deadline for manuscript submissions: 1 March 2025

“2nd Edition: Pregnancy and Perinatal Health”
Guest Editors: Prof. Dr. Claude Billeaud and Dr. Virginie Rigourd
Deadline for manuscript submissions: 31 August 2024

“Nutritional Management of Newborn Infants”
Guest Editor: Dr. Maria Skouroliakou
Deadline for manuscript submissions: 27 November 2024

“Pregnancy, Childbirth, Puerperium, Breastfeeding and Sexuality in the World of Rare Diseases”
Guest Editors: Dr. Juan Carlos Sánchez-García, Dr. Raquel Rodríguez-Blanque and Dr. Jonathan Cortés Martín
Deadline for manuscript submissions: 30 September 2024

The following is an interview with Dr. Federica Laudisi:

1. Could you please provide a brief introduction of yourself to our readers?
I am a mucosal immunologist, with strong expertise in human chronic inflammatory pathologies. After getting my Ph.D. in immunology in Rome at Sapienza University, I spent three years at the A*STAR-Singapore Immunology Network (SigN) in Singapore and one year at the Charitè Universitӓtsmedizin in Berlin. In 2015, I joined the laboratory of Prof. Giovanni Monteleone at the University of Rome “Tor Vergata”, focusing my research on gut inflammation and cancer. I am currently setting up my group here.

2. Could you please briefly introduce the main content of the winning paper?
This paper describes the importance of the intestinal epithelial barrier in maintaining gut homeostasis and ensuring the critical crosstalk between gut microbes (both commensals and pathogens) and the host’s immune system. We also describe potential alterations (either genetic or related to the environment) that may undermine such equilibrium, thus leading to gut dysbiosis. This pathological condition is now recognized to trigger the onset of several diseases, such as inflammatory bowel diseases and colorectal cancer. Indeed, targeting intestinal barrier dysfunctions represents a fascinating and challenging approach to treating gut-related diseases.

3. What is your current research and why did you choose this research field?
My research interests focus on the genetic, cellular, and environmental factors underlying chronic inflammatory bowel diseases, as well as mechanisms and inflammatory/neoplastic signals that sustain and amplify colon carcinogenesis.

4. Which research topics do you think will be of particular interest to the research community in the coming years?
I believe that research topics concerning microbiota targeting (including mycobiome and virome), as well as the host’s immune response modulation, may be of particular interest to the research community in the coming years since they are now considered a valuable and promising strategy to prevent and/or treat gut-related diseases.

5. What appealed to you about the journal that made you want to submit your paper? What benefits do you think authors can gain when publishing their articles in Biomedicines?
Biomedicines is a multidisciplinary journal that attracts a number of experts in different scientific fields. Therefore, in my view, this increases the visibility of your research among the research community. Moreover, the open access format, as well as the social media sharing, importantly contribute to disseminating your work.

6. How was your experience submitting to Biomedicines?
My experience submitting to Biomedicines was positive. The whole submission procedure was easy and clear to follow. I also appreciated the quickness of the revision since we received a first decision within two weeks, and this is a very important aspect to be considered in publishing scientific articles.

7. Can you briefly describe the key to a happy laboratory life? Have you ever encountered any difficulties conducting research and how did you overcome them?
I believe that the key to a happy laboratory life is to create a positive and balanced atmosphere in your teamwork. We are a group of scientists working together many hours per day and many days per year. We share successes and frustrations. Everyone is an important cog in the wheel, and it is not possible to reach ambitious goals without the help of your colleagues.
Sure, I have encountered many difficulties conducting research at every step of my career. We should not be afraid of failures and troubles; they are part of our lives. They make you stronger; they make your goals more defined and clearer. I try to be resilient and cultivate my passion for science, despite everything.

8. We are an open access journal. How do you think open access impacts the authors?
As I mentioned previously, being an open access journal gives a lot of advantages to the authors, since it helps to share your research more easily among the scientific community. Moreover, it allows low-income countries to read your work and take inspiration for further in-depth studies, thus helping the growth of the research community.

9. As the winner of this award, is there something you want to express or someone you wish to thank most?
I would like to thank the co-authors who helped me to conceptualize and draft this paper. A special thanks goes to Prof. Giovanni Monteleone. I am grateful for his support and guidance throughout my career.

More information about journal awards can be found at the following link: https://www.mdpi.com/journal/biomedicines/awards.

A range of MDPI journals will be attending the 46th ESPEN Congress in Milan, Italy, from 7 to 10 September 2024.

ESPEN 2024 offers a great opportunity for physicians, dietitians, pharmacists, nutritionists, scientists and nurses involved in the field of nutrition and metabolism to meet and discuss cutting-edge science in an informal atmosphere, strengthening old and creating new collaborations.

The following MDPI journals will be represented:

• Nutrients;
• Medicina;
• Obesities;
• CIMB;
• Children;
• Metabolites;
• Biomedicines;
• Sci;
• Dietetics;
• Geriatrics;
• Women.

If you are attending this conference, please feel free to engage with us at our booth. Our delegates look forward to meeting you and answering any questions that you may have. For more information about the conference, please visit https://espencongress.com/ or contact the Nutrients Editorial Office at [email protected].

MDPI will be attending the 46th Congress of the Spanish Society of Biochemistry and Molecular biology (46th SEBBM Congress), which will be held from 3 to 6 September 2024 in A Coruña, Spain.

The 46th SEBBM Congress will enjoy a wide range of plenary conferences, symposia, including the Hispanic-Luso Scientific Symposium and the Scientific Symposium of Education, meetings of the scientific groups of SEBBMs, poster sessions and the commercial exhibition of collaborating companies. We will be able to enjoy satellite activities such as the Research Initiation Course in Biochemistry and Molecular Biology, the Professional Development Forum for Young Researchers, and the activities of Biochemistry in the city, with exhibitions, scientific–artistic shows, round tables and scientific workshops.

The following MDPI journals will be represented at the conference:

• Cells;
• Biomolecules;
• CIMB;
• IJMS;
• Biomedicines;
• Organoids;
• Biology;
• BioTech;
• Biologics;
• Diagnostics;
• Medicina;
• BioMedInformatics;
• JMP;
• Genes.

If you are planning to attend the above conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have.

For more information about the conference, please visit the official website at https://congresos.sebbm.es/coruna2024/.

Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy | Editorial | view inaugural issue	anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article
	Dr. Giovanni E. Cacciamani, University of Southern California, USA | Editorial | view inaugural issue	surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article
	Prof. Dr.  Gassan Hodaifa, Universidad Pablo de Olavide, Spain | Editorial | view inaugural issue	laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article
	Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA | Editorial | view inaugural issue	companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article
	Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy | Editorial | view inaugural issue	real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.

We are pleased to share that Biomedicines (ISSN: 2227-9059) was awarded an updated Impact Factor of 3.9 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024, ranking in Q1 (85 among 354 titles) in the “Pharmacology and Pharmacy” category.

Additionally, according to data released by Scopus (Elsevier), Biomedicines received an increased CiteScore™ of 5.2, showing an increase of 40.5% compared to 2022.

Biomedicines’ CiteScore ranks as follows:

• Q2 (103 out of 398 journals) in the “Medicine (miscellaneous)” category;
• Q2 (74 out of 221 journals) in the “General Biochemistry, Genetics and Molecular Biology” category.

For further statistics, please visit https://www.mdpi.com/journal/biomedicines/stats. For more information about MDPI flagship journals' citation metrics, please see here.

At MDPI, our mission is simple, yet powerful—we strive every day to make scientific research freely accessible to everyone, everywhere. With over 3.5 million authors choosing MDPI, we have established ourselves as a key player driving the open access initiative.

Our journals have received over 13 million citations in the Web of Science, making us the most cited open access publisher. With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services.

Biomedicines Editorial Office

MDPI will attend the ASHG Annual Meeting 2024, held in Denver, Colorado, USA, from 5 to 9 November 2024.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

• Genes;
• IJMS;
• Biomedicines;
• Diagnostics;
• Cancers;
• Biomolecules;
• Humans;
• Applied Biosciences;
• DNA;
• Cardiogenetics;
• Vaccines;
• Life;
• Epigenomes;
• Biology;
• CIMB;
• JCDD;
• ncRNA;
• Diseases;
• BioMed;
• Biomedinformatics.

If you plan on attending this conference, please stop by our booth #1058 and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following link: https://www.ashg.org/meetings/2024meeting/.

MDPI is pleased to announce the inclusion of 237 journals in the 2024 release of the Journal Citation Reports (JCR) and share the key results (see above).

This year, journals covered in the Emerging Sources Citation Index (ESCI) received category ranks together with journals in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI). Overall, 139 MDPI journals indexed in ESCI are included in the new unified rankings for the first time.

Enhanced Comparability of Data

According to Clarivate, "the creation of unified category rankings [provides] a simpler and more complete category view for the evaluation of journal performance. [...] The category-first approach simplifies journal performance assessment with a holistic view of all journals in each subject category."

We are thrilled to announce that 72% of our ranked MDPI journals (171 of 237) are above average, in Q1 or Q2. Twenty-nine of our journals received their first Impact Factor this year, accounting for more than 5% of the journals accepted into the Web of Science last year.

MDPI Journals Ranked in JCR

The following data includes all MDPI journals indexed in SCIE, SSCI, ESCI and AHCI.

Source: 2023 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2024)

About MDPI

A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 professional, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 440 fully open access titles.

We are pleased to announce the winners of the Biomedicines 2022 Best Paper Award for Anniversary Special Issues. All papers published in 2022 in Anniversary Special Issues were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, six winners were selected.

First Prize: CHF 800 plus a paper free of charge after peer review
“Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity”
by Stefania Scalise, Clara Zannino, Valeria Lucchino, Michela Lo Conte, Luana Scaramuzzino, Pierangelo Cifelli, Tiziano D’Andrea, Katiuscia Martinello, Sergio Fucile, Eleonora Palma et al.
Biomedicines 2022, 10(5), 1075; https://doi.org/10.3390/biomedicines10051075

Second Prize: CHF 500
“Assessing the Future of Solid Tumor Immunotherapy”
by Prajna Guha, Kara R. Heatherton, Kyle P. O’Connell, Ian S. Alexander and Steven C. Katz
Biomedicines 2022, 10(3), 655; https://doi.org/10.3390/biomedicines10030655

“Gastrointestinal Microbiome and Neurologic Injury”
by Eric J. Panther, William Dodd, Alec Clark and Brandon Lucke-Wold
Biomedicines 2022, 10(2), 500; https://doi.org/10.3390/biomedicines10020500

Third Prize: CHF 300
“Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae”
by Iñaki Milton-Laskibar, Amanda Cuevas-Sierra, María P. Portillo and J. Alfredo Martínez
Biomedicines 2022, 10(8), 1797; https://doi.org/10.3390/biomedicines10081797

“Targeting Adiponectin in Breast Cancer”
by Rawan Nehme, Mona Diab-Assaf, Caroline Decombat, Laetitia Delort and Florence Caldefie-Chezet
Biomedicines 2022, 10(11), 2958; https://doi.org/10.3390/biomedicines10112958

“Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options”
by Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Giuseppe Loffredo, Luca Rinaldi, Christian Catalini, Klodian Gjeloshi, Gaetana Albanese, Anna Di Martino et al.
Biomedicines 2022, 10(9), 2274; https://doi.org/10.3390/biomedicines10092274

Please join us in congratulating the winners of the Biomedicines 2022 Best Paper Award for Anniversary Special Issues. We would also like to take this opportunity to thank all of our authors for your continued support of Biomedicines (ISSN: 2227-9059).

Biomedicines Editorial Office

On UNESCO’s 2024 Oceans Day, MDPI encourages the scientific community to increase the accessibility of ocean research to accelerate ocean conservation.

Basel, Switzerland, June 7, 2024: MDPI, a leading open access (OA) publisher, is proud to announce its active support for World Oceans Day 2024, celebrated under UNESCO’s Ocean Decade framework. MDPI’s CEO, Stefan Tochev hopes that “the latest ocean research can be made freely accessible to help empower scientists and communities at large to save our oceans,” under UNESCO’s Ocean Decade until 2030.

Open Access: A Catalyst for Ocean Action

MDPI’s presence at the UNESCO Ocean Decade Conference 2024 highlights our unwavering commitment to using OA to advance ocean science, support research communities, and promote sustainable ocean management.

"Our involvement in the UNESCO Ocean Decade Conference underscores MDPI's commitment to the underfunded Ocean SDG. By promoting OA to scientific articles and books on SDGs, we aim to inspire critical actions," said Tochev. "Our initiatives, like the World Sustainability Award and Emerging Sustainability Award, further demonstrate our dedication to advancing sustainability.”

Showcasing MDPI’s Contributions to Ocean Research

Over the past three years, MDPI has published 30,000 papers focused on ocean research and related topics. Key MDPI journals contributing to this body of work include:

• Journal of Marine Science and Engineering (4.9k papers)
• Remote Sensing (2.6k papers)
• Sustainability (2k papers)
• International Journal of Molecular Sciences (IJMS) (1.7k papers)
• Marine Drugs (1.5k papers)
• Water (1.5k papers)

These publications highlight MDPI’s contributions to ocean science, reinforcing our role in the broader sustainability agenda by promoting blue innovation and economy.

Additionally, MDPI has launched Oceans, an international, peer-reviewed forum specifically aimed at publishing studies related to all branches of oceanography with an emphasis on the functioning of the ocean and the sustainable use of its resources and ecosystem services.

Affirming MDPI’s Commitment to Ocean Science

MDPI’s commitment to OA is pivotal in addressing critical global challenges, from climate change to ocean sustainability. Our efforts resonate with Outcome 4 of the UNESCO Ocean Decade action roadmap: an accessible ocean with open and equitable access to data, information, technology, and innovation. By aligning with UNESCO’s goals, MDPI continues to contribute to shaping a sustainable future for our oceans, reinforcing our position as a forward-thinking publisher dedicated to environmental stewardship and scientific excellence.

For more information, contact Rui Duarte at [email protected] or +41764313242.

About MDPI

95% of authors rate MDPI’s publication process as excellent or good, setting a new benchmark in scientific publishing – reveals 2023 Annual Report. 

Basel, Switzerland, June 4, 2024: MDPI, the leading open access (OA) publisher, proudly announces the release of its 2023 Annual Report, detailing remarkable achievements and reaffirming its leadership in advancing OA publishing. In 2023, MDPI received 655,065 submissions, of which 285,244 articles were published. The company now commands a 17% market share in gold open access articles, with a median publication time of six weeks.

Stefan Tochev, MDPI's CEO, stated, "As a pioneer in open access publishing, MDPI has long been a game-changer in the scholarly community, serving millions of authors around the world to ensure the latest research is freely available. Reflecting on our incredible journey at MDPI, 2023 has been marked by growth in paper submissions, ambitious projects and initiatives aimed at improving our internal processes and delivering top-notch services to our scientists."

MDPI's 2023 Annual Report highlights several key achievements:

• 17% market share in gold open access articles across all disciplines.
• Record satisfaction rates: 95% of authors, 82% of reviewers, and 85% of guest editors.
• Enhanced editorial standards and feedback processes.
• Increased reach and impact with 54 new MDPI journal inclusions in Scopus, 29 in Web of Science, and 77 in DOAJ.

MDPI’s unwavering commitment to advancing OA has transformed the landscape of scholarly publishing, making high-quality research freely accessible to the global scientific community. The continuous improvement in our editorial standards and feedback processes underscores MDPI’s dedication to ensuring academic integrity and excellence.

Global Reach and Collaboration

MDPI’s global footprint continues to expand, with authors from diverse regions: 37% from Asia/Pacific, 36% from Europe, 15% from the Americas, and 12% from other parts of the world. The company’s fully OA platform attracted nearly 14 million monthly visitors in 2023, reflecting its widespread influence in the scientific community.

Commitment to Partnerships

With over 800 institutional partners, MDPI continues to demonstrate its dedication to providing reliable and collaborative publishing services. The introduction of a transparent flat-fee model highlights MDPI's ongoing efforts to enhance affordability and support to the academic community. For more details read our 2023 Annual Report.

For more information, contact Rui Duarte at [email protected] or +41764313242.

About MDPI

The ESMO Congress is a globally influential oncology platform that unites clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2024 will disseminate the latest cutting-edge data, providing high-quality education and excellent networking opportunities for oncologists and other stakeholders on an international level.

The following MDPI journals will be represented:

• Cancers;
• JCM;
• Healthcare;
• Pharmaceutics;
• Applied Biosciences;
• Dermatopathology;
• Onco;
• Biomedicines;
• Cells;
• Diagnostics;
• Current Oncology;
• Immuno;
• Hemato;
• Gastrointestinal Disorders;
• Biologics;
• Biomolecules;
• Clinics and Practice;
• Medical Sciences.

If you are participating in this conference, please feel free to engage with us online prior to attendance. Our delegates look forward to meeting you in person at booth #P627 and answering any questions you may have. For more information regarding the conference, please visit the following link: https://www.esmo.org/meeting-calendar/esmo-congress-2024.

MDPI will attend the 10th Congress of the European Academy of Neurology, held in Helsinki, Finland, from 29 June to 2 July 2024, at booth #E28. We invite researchers from different backgrounds to visit and share their latest ideas with us.

The EAN Congress covers “big diseases” such as multiple sclerosis, movement disorders, headache, muscle disorders, epilepsy, dementia, and stroke, as well as breakthrough research on rare diseases. This edition will celebrate 10 years of the EAN with over 8000 professionals. The 10th EAN Congress's overarching theme is “Neuromodulation: Advances and Opportunities in Neurological Diseases”. Leading specialists will tackle hot topics in invasive and non-invasive neuromodulation in movement and cognitive disorders, chronic pain, and refractory epilepsy. The current state and future directions of neuromodulation will be addressed with relevant questions regarding which techniques are available as diagnostic tools or therapeutic interventions; how to precisely target specific cortical regions, deep brain structures, and head nerves for therapeutic purposes; and how to advance neuromodulation in new areas of neurology such as chronic minimally conscious state or limb prosthesis.

The following MDPI journals will be represented at the conference:

• Biomedicines;
• Clinical and Translational Neuroscience;
• Brain Sciences;
• Biomolecules;
• Cells;
• Current Issues in Molecular Biology;
• Diagnostics;
• Genes;
• Healthcare;
• International Journal of Translational Medicine;
• Journal of Clinical Medicine;
• Life;
• Muscles;
• Methods and Protocols;
• Neuroglia;
• Neurology International;
• Vaccines.

If you are planning to attend the conference, please feel free to start a conversation with us at our booth #E28. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.ean.org/congress2024.

Conference: FENS Forum 2024
Date: 25–29 June 2024
Location: Vienna, Austria

MDPI will be attending FENS Forum 2024 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the Federation of European Neuroscience Societies (FENS), the Austrian Neuroscience Association (ANA) and and the Hungarian Neuroscience Society. The FENS Forum is Europe’s largest neuroscience congress, covering all areas of neuroscience from basic to translational research.

The following MDPI journals will be represented:

• Brain Sciences;
• Journal of Clinical Medicine (JCM);
• Cells;
• NeuroSci;
• Neuroglia;
• Biomedicines;
• Neurology International;
• Behavioral Sciences;
• Psychoactives.

If you are planning on attending this conference, please do not hesitate to contact us. Our delegates look forward to meeting you in person at booth #1003, and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.fens.org/meetings/fens-forum/upcoming-fens-forums.

We are pleased to announce MDPI’s Transfer Service.

This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.

We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:

1. Select alternative journals on submission.

2. Authors are encouraged to transfer manuscripts to other MDPI journals.

More details about the Transfer Service can be found at the following link:

https://www.mdpi.com/authors/transfer-service

Although the worst of the SARS CoV-2 pandemic is behind us, many questions and issues persist. Systemic manifestations due to COVID-19 infections and long COVID continue to emerge in multiple countries. There are a few new USA FDA-approved vaccines available in addition to the Moderna, Pfizer, and Johnson and Johnson ones, but vaccine effectiveness and immunologic memory appear to be limited in most patients. Therapies are available and should be incorporated into treatment plans for COVID-19 patients. Although the focus of these therapies is on hospitalized COVID-19 patients, orally delivered medications are now administered by health care providers.

This webinar will present discussions on these issues, as well as emerging trends, to understand COVID-19 infections and transmissibility more fully.

Date: 4 June 2024 at 5:00 CEST | 11:00 a.m. EDT | 11:00 p.m. CST Asia
Webinar ID: 828 4947 7200
Webinar Secretariat: [email protected]
Webinar Announcement: https://sciforum.net/event/Biomedicines-14

After registering, you will receive a confirmation email containing information on how to join the webinar.
Registrations with academic or institutional email addresses will be prioritized.

Unable to attend? Feel free to still register, and we will inform you when the recording is available.

Register now for free!

Webinar Chair and Keynote Speakers:

• Jon Suzuki (Chair), ¹University of Maryland, USA, ²University of Washington, USA, ³Nova Southeastern University, USA, ⁴Temple University, USA;
• Rosalinda Sorrentino, University of Salerno, Italy;
• Stefano D’Errico, University of Trieste, Italy;
• Miriana D’Alessandro, University of Siena, Italy;
• Sara Gangi, University of Siena, Italy.

Relevant Special Issue:
“Emerging Trends in Pathophysiology and Therapy of COVID-19”
Guest Editors: Dr. Jon Suzuki and Dr. Miriam Ting

In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.

Prize:

• CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
• An award medal for each winner.

Who should be nominated?

• Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Who can submit a nomination?

• Academic research institutes
• Universities
• Academic societies

Any personal nominations are not accepted.

How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.

Required nomination materials:
Nomination Form (Download)

Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.

Contact:
Tu Youyou Award Team ([email protected])

More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.

MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.

The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.

On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.

Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.

Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.

MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.

MDPI will attend the 34th CCS Congress, which will be held in Guangzhou, Guangdong Province, China, from 15 to 18 June 2024. Registration for the event opens on 14 June.

This annual congress is hosted by the Chinese Chemical Society (CCS). With the support and active participation of chemists across the country, the annual academic conference of the Chinese Chemical Society has continued to expand in scale and influence and has become a comprehensive academic exchange platform with the most comprehensive categories, the largest scale, and the highest level in chemistry and related fields. The theme of the 34th CCS Congress is “Toward Higher Quality Chemistry Research”. It has established 70 academic branches. The forms of academic exchange include conference plenary reports (PL), keynote reports (KN), invited reports (I), oral reports (O), flash reports (F), and poster reports (P). The annual meeting collects academic papers (abstracts) from chemists. Workers in scientific research, teaching, and industry in chemistry and related fields are welcome to submit papers and actively participate in the meeting.

A series of colorful forums, continuing education, and other activities will be held simultaneously during the annual meeting. An exhibition will also be held, inviting the support and active participation of relevant universities and research institutes, enterprises, book publishing, and academic journals.

The following MDPI journals will be represented at the conference:

• Molecules;
• International Journal of Molecular Sciences;
• Polymers;
• Biomedicines;
• Inorganics;
• Processes;
• Symmetry;
• Separations;
• Membranes;
• Materials;
• Reactions;
• Chemistry;
• Compounds;
• Biomolecules;
• Sustainable Chemistry;
• Chemosensors;
• Applied Sciences.

If you are planning on attending this conference, please do not hesitate to stop by our booth #B37 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.chemsoc.org.cn/meeting/34th/.